These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2122552)

  • 1. Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected].
    Lyden PD; Madden KP; Clark WM; Sasse KC; Zivin JA
    Stroke; 1990 Nov; 21(11):1589-93. PubMed ID: 2122552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed treatment with a t-PA analogue and streptokinase in a rabbit embolic stroke model.
    Phillips DA; Fisher M; Davis MA; Smith TW; Pang RH
    Stroke; 1990 Apr; 21(4):602-5. PubMed ID: 2109376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].
    Benes V; Zabramski JM; Boston M; Puca A; Spetzler RF
    Stroke; 1990 Nov; 21(11):1594-9. PubMed ID: 2122553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits.
    Clark WM; Madden KP; Lyden PD; Zivin JA
    Stroke; 1991 Jul; 22(7):872-6. PubMed ID: 1906646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy in acute ischemic stroke.
    Clark WM; Lyden PD; Madden KP; Zivin JA
    N Engl J Med; 1997 Jan; 336(1):65-6; author reply 66-7. PubMed ID: 8984333
    [No Abstract]   [Full Text] [Related]  

  • 6. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.
    Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Keyt BA; Refino CJ; Zivin JA; Bennett WF
    Stroke; 1994 Oct; 25(10):2072-8; discussion 2078-9. PubMed ID: 8091454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of TNK with wild-type tissue plasminogen activator in a rabbit embolic stroke model.
    Chapman DF; Lyden P; Lapchak PA; Nunez S; Thibodeaux H; Zivin J
    Stroke; 2001 Mar; 32(3):748-52. PubMed ID: 11239197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
    Aylward PE; Wilcox RG; Horgan JH; White HD; Granger CB; Califf RM; Topol EJ
    Ann Intern Med; 1996 Dec; 125(11):891-900. PubMed ID: 8967669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolytic therapy in cerebrovascular disorders.
    Levine SR; Brott TG
    Prog Cardiovasc Dis; 1992; 34(4):235-62. PubMed ID: 1728786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Gebel JM; Sila CA; Sloan MA; Granger CB; Mahaffey KW; Weisenberger J; Green CL; White HD; Gore JM; Weaver WD; Califf RM; Topol EJ
    Stroke; 1998 Mar; 29(3):563-9. PubMed ID: 9506593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits.
    Lyden PD; Zivin JA; Clark WA; Madden K; Sasse KC; Mazzarella VA; Terry RD; Press GA
    Neurology; 1989 May; 39(5):703-8. PubMed ID: 2496332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.
    Gore JM; Granger CB; Simoons ML; Sloan MA; Weaver WD; White HD; Barbash GI; Van de Werf F; Aylward PE; Topol EJ
    Circulation; 1995 Nov; 92(10):2811-8. PubMed ID: 7586246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TPA within 3 hours of acute ischaemic stroke?
    Dorman P; Sandercock P
    Lancet; 1996 Dec; 348(9042):1600-1. PubMed ID: 8961984
    [No Abstract]   [Full Text] [Related]  

  • 14. "Brain attack": an indication for thrombolysis?
    Fagan SC; Zarowitz BJ; Robert S
    Ann Pharmacother; 1992 Jan; 26(1):73-80. PubMed ID: 1606347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
    Thomas GR; Thibodeaux H; Bennett WF; Refino CJ; Badillo JM; Errett CJ; Zivin JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):67-73. PubMed ID: 8423552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2000 Dec; 31(12):3034-40. PubMed ID: 11108768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits.
    Bowes MP; Zivin JA; Thomas GR; Thibodeaux H; Fagan SC
    Exp Neurol; 1996 Sep; 141(1):40-6. PubMed ID: 8797666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteplase for thrombolysis in acute ischemic stroke.
    Med Lett Drugs Ther; 1996 Nov; 38(987):99-100. PubMed ID: 8914507
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Purdy R; Zivin JA
    Stroke; 2002 Jun; 33(6):1665-70. PubMed ID: 12053009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.